Why doesn't my immune system just clear this?

Understanding the two-tier immune response explains everything that follows — why Lyme can hide, why tests fail early, and why treatment takes time.

Your immune system operates in two coordinated layers. The innate immune system is your rapid-response force — it activates first and attacks anything that looks foreign. The adaptive immune system is your precision force — it takes longer to come fully online but creates targeted antibodies and memory cells specific to the exact pathogen you're fighting.

Both are activated by Lyme disease. Both are partially defeated by Borrelia burgdorferi through mechanisms that have evolved over millions of years of co-existence with mammalian hosts. Understanding what each system does — and how Borrelia evades each — explains why Lyme behaves so differently from other bacterial infections.

• Innate Immune System

  Your first responders. Activates first. Includes neutrophils, macrophages, NK cells, and the complement system. Recognizes general patterns of foreign invaders — not specific pathogens.

  Innate · Fast · General

• Adaptive Immune System

  Your precision force. Slower to start. B cells produce specific antibodies. T cells destroy infected cells. Creates immunological memory — the basis of vaccines and why you don't get the same illness twice.

  Adaptive · Slow · Specific

• Why Both Matter for Lyme

  Borrelia has evolved to partially disable both systems simultaneously. It disrupts the innate response before it can signal the adaptive one, then disables the adaptive response before it can create lasting immunity. This two-front attack is why Lyme is so different from a simple bacterial infection.

  Both systems targeted

In the hours after a tick deposits Borrelia into your skin, your immune system launches a coordinated response — one Borrelia has specifically evolved to disrupt.

When Borrelia spirochetes enter your skin via tick saliva, your innate immune system's pattern recognition receptors (PRRs) — specifically TLR2 (Toll-Like Receptor 2) — detect bacterial surface proteins and trigger an inflammatory response. This is the right response. The problem is that Borrelia anticipated it.

The tick's saliva — which carries a large number of compounds that damp the local immune response, described in the Understanding Ticks guide — acts as Borrelia's advance team. By the time your immune system signals for reinforcements, Borrelia has already moved beyond the bite site. This is why prompt tick removal matters so much — more feeding time is more immunosuppressant delivered, and more establishment time for the bacteria.

• What Should Happen

  TLR2 detects Borrelia → triggers NF-κB signaling → releases pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) → recruits neutrophils and macrophages → phagocytosis kills bacteria → adaptive response activates → antibodies produced → infection cleared.

  Normal bacterial infection

• What Actually Happens with Lyme

  TLR2 detects Borrelia → signal is partially suppressed by tick saliva immunosuppressants already present → cytokine response is blunted → fewer immune cells recruited → Borrelia escapes into tissue and bloodstream before immune cells arrive → establishes disseminated infection.

  Tick-assisted evasion

Six specific strategies Borrelia uses to survive inside a host whose immune system is actively trying to kill it.

Borrelia burgdorferi is capable of establishing a persistent infection despite the activation of both innate and adaptive immune responses. It utilizes several immune evasion tactics including the regulation of surface proteins, tick saliva assistance, antimicrobial peptide resistance, and the disabling of the germinal center.

1. 01

   Surface Protein Switching (Antigenic Variation)

   Borrelia continuously changes the proteins on its outer surface — specifically a protein called VlsE (Variable major protein-Like Sequence, Expressed). When your adaptive immune system finally produces antibodies targeting one surface protein configuration, Borrelia changes it. Your antibodies no longer fit the lock. The adaptive immune response has to start over. This is one of the primary reasons Lyme can persist despite a mounted immune response.

   Why it matters: This is why the immune system never builds lasting protective immunity to Lyme — the target keeps moving. It's also why vaccines have been difficult to develop.

2. 02

   Complement System Hijacking

   The complement system is your body's chemical weapon against bacteria — a cascade of proteins that punch holes in bacterial membranes and kill them. Borrelia disables the complement system through the regulation of outer surface proteins and the binding of complement regulators. Specifically, Borrelia binds your own complement regulatory proteins (Factor H, FHL-1) to its surface, disguising itself as "self" and preventing the complement cascade from activating against it.

   Why it matters: One of the most important innate immune weapons is neutralized. Borrelia essentially borrows your own "don't attack me" signal.

3. 03

   Germinal Center Collapse

   The adaptive immune response is disabled through the invasion of the lymph nodes by Borrelia, and the resulting collapse of the germinal center, the lack of memory cell production, and antibody class switching. The germinal center is where your B cells mature into antibody-producing plasma cells and memory cells. By invading lymph nodes and disrupting this process, Borrelia prevents the production of long-term immune memory — which is why you can be re-infected with Lyme.

   Why it matters: Explains why you don't develop lasting immunity to Lyme after infection — and why re-infection is possible after treatment.

4. 04

   Intracellular Hiding

   Borrelia has been shown to invade and shelter inside host cells — including synovial cells (joint tissue), endothelial cells (blood vessel lining), and possibly neurons. Inside a cell, bacteria are out of reach of antibodies, which work in the bloodstream and the extracellular space. How much of this happens in people, and whether it is enough to carry an infection through a course of antibiotics, is one of the places the evidence runs out.

   Why it matters: Intracellular refuge is one of the mechanisms put forward in the debate over whether longer antibiotic courses help — a debate the trials to date have not settled. It is also part of why antibiotics that enter cells, such as doxycycline, are chosen for Lyme.

5. 05

   Immune Exhaustion

   Current research suggests that the immune system has important immune checkpoints that regulate immune responses, leading to a state of "immune exhaustion" during chronic infections. After months of fighting a persistent infection, T cells upregulate inhibitory receptors (PD-1, CTLA-4) that essentially tell the immune system to stand down. This is a normal safeguard against autoimmunity. Some researchers propose that Borrelia could take advantage of it; that has been described in the laboratory and in other chronic infections, and whether it happens in people with Lyme is not established.

   Why it matters: it is one proposed explanation for why symptoms can continue — a hypothesis under study, not an established finding.

6. 06

   Pleomorphism — Shape Shifting

   In the laboratory, Borrelia has been observed in more than one form: the spirochete form (active and motile), a round-body or cyst form, and aggregated communities described as biofilm. Those forms have been produced and photographed under laboratory conditions. Whether they form inside people, how long they last there, whether they respond differently to antibiotics, and whether they have anything to do with relapse are open questions rather than established facts — and this page does not settle them.

   Why it matters: Round-body and biofilm forms are described in the laboratory; whether they occur in people, and whether they explain relapse, is not resolved. The debate over treatment length partly turns on that question, and extended or combination protocols are one side's answer to it.

The immune evasion mechanisms above have a direct consequence for testing — and understanding it explains one of the most common and frustrating Lyme experiences.

The two-tier testing algorithm — an EIA, then either an immunoblot or a second EIA — detects antibodies your immune system produces against Borrelia, not the bacteria itself. This creates a fundamental timing problem. The Testing Guide walks through the algorithm step by step.

• The Antibody Window

  Your adaptive immune system needs time to produce antibodies at levels a test can detect. Until it has, you can be genuinely infected and test completely negative — not because the test failed, but because your body has not answered yet. This is the period when a negative result is expected rather than reassuring, and no figure on a web page can tell you where in it you are.

• Antigenic Variation's Testing Impact

  The standard test detects antibodies against specific Borrelia surface proteins. Because Borrelia continuously changes its surface proteins (VlsE variation), the antibodies your body produces may not match what the test is looking for. Some specialty laboratories report against wider antigen panels for this reason. Mainstream bodies hold that testing outside the validated two-tier algorithm has not demonstrated sufficient accuracy for routine clinical use; Lyme-literate clinicians and many patients hold that the standard algorithm misses real infections. The Testing Guide names the labs, what each one reports, and what it typically costs.

• Immune Suppression's Testing Impact

  Because Borrelia suppresses the adaptive immune response and collapses germinal centers, some patients never produce robust antibody levels — even with active infection. The resulting immune response is characterized by unusually strong IgM production and a lack of long-term protective immunity. Weak IgG antibodies mean negative or equivocal tests even in later infection.

Antibiotics don't replace your immune system — they reduce the bacterial load to a level your immune system can finally handle.

A common misconception is that antibiotics "kill all the bacteria." More precisely, antibiotics disable bacterial functions in ways that stop reproduction and make bacteria vulnerable to immune clearance. Different antibiotics work through fundamentally different mechanisms, which is why the same drug that treats Lyme does not treat Babesia — a parasite does not answer to a drug built to interrupt bacterial protein synthesis.

Which medicines are used, in what combination, and for how long is a clinical decision and is not described here. The Treatment Protocols guide sets out the structure of treatment and where the two major guideline bodies part company; it gives no doses or durations either, and for the same reason.

Each coinfection adds a separate immune challenge — and some coinfections actively suppress the immune response against the others.

When a tick transmits more than one pathogen — Lyme plus Babesia, for example — your immune system doesn't just have two separate battles. The coinfections interact. Some pathogens actively suppress immune responses that would help clear the others. Treating Lyme alone while a coinfection goes unaddressed is one reason symptoms can continue even after appropriate antibiotic treatment for Lyme itself.

• Babesia's Immune Impact

  Babesia infects and destroys red blood cells, causing hemolytic anemia. This reduces oxygen delivery to all tissues including immune cells. An oxygen-deprived immune system functions at reduced capacity — which simultaneously makes it harder to fight both Babesia and any concurrent Lyme infection. Babesia also induces a strong IFN-γ response that can paradoxically suppress other arms of the immune system.

• Bartonella Is a Different Question

  Bartonella is spread to people mainly by fleas, body lice and sand flies, and by scratches from flea-infested cats. CDC states there is no evidence that ticks spread Bartonella to people. It has been found in ticks, and one laboratory study showed a tick passing it to an animal; whether that happens in nature is not known. Some clinicians who treat persistent illness after a tick bite consider it anyway — a proposed route of infection, not an established one. So it is not an example of what one tick bite does to the immune system, and this chapter does not use it as one.

• The Compounding Effect

  Each pathogen requires immune resources. Each evasion mechanism compounds the others. A person with Lyme and Babesia together has two pathogens working on different immune pathways at once. Some coinfections, such as Babesia, are not treated by the antibiotics used for Lyme, which is why coinfection testing is worth asking about rather than assuming.

The immunological explanation for why symptoms can worsen after treatment starts — and why worsening on its own cannot tell you which of several very different things is happening.

When antibiotics kill Borrelia spirochetes, the dying bacteria release their cellular contents — including lipoproteins and cell wall fragments — into your bloodstream and tissues. Your immune system recognizes these fragments as foreign and launches an inflammatory response to clear them.

This rapid inflammatory response — cytokine storm involving IL-6, TNF-α, and IL-1β — is the Jarisch-Herxheimer reaction. It's the same inflammatory cascade your immune system uses against active infection, but now triggered by bacterial debris rather than live bacteria. The result is a temporary but often intense worsening of symptoms.

• What's Released When Bacteria Die

  Borrelia has no lipopolysaccharide (LPS) — the endotoxin many other bacteria carry — so the endotoxin explanation often given for this reaction does not apply to it. What it does carry is lipoproteins, which activate TLR2, the same receptor that detects live Borrelia. DNA fragments activate inflammatory pathways too. When bacteria are killed in bulk, these are released together.

• The Cytokine Response

  The immune system responds with a rapid release of pro-inflammatory cytokines — IL-6, TNF-α, IL-1β, IL-8. These produce the symptoms usually described with this reaction: fever, chills, sweating, worsening fatigue, joint pain, and brain fog. How soon it starts and how long it lasts vary widely between people, and this page deliberately gives no window — a number here would read as a deadline to wait out, and these same symptoms have other causes, some of them urgent.

• Symptoms That Come in Waves

  Many people describe symptoms that come and go in waves rather than easing steadily, and Borrelia does grow slowly compared with most bacteria. Those two observations are often linked to each other in patient communities, but no replication cycle or symptom cycle has been established in people. A pattern in your symptoms cannot tell you whether treatment is working, whether it is failing, or whether something else is going on — that question needs a clinician who can examine you.

You cannot supplement your way out of Lyme. What follows is what people commonly take alongside conventional treatment, what each is thought to do, and how much is actually known about it — which for most of this list is much less than the marketing suggests.

The idea behind immune support during Lyme treatment is not to replace antibiotics. It is to look after the systems that antibiotics are hard on — the gut in particular. Whether any of it changes the course of the infection itself is, for almost everything below, unknown, and the evidence tier on each entry says which of those two things is being claimed.

• Probiotics

  Gut Microbiome

  Antibiotics can kill helpful gut bacteria as well as harmful ones, which disrupts the balance of the gut microbiome. A large share of the body's immune tissue sits in the gut wall as gut-associated lymphoid tissue (GALT), which is why gut disruption is discussed as an immune question and not only a digestive one.

  Clinical (general): Human studies exist for antibiotic-associated gut disruption in general. None show an effect on Lyme itself.

  Interaction: Supplements can interact with prescription medicines. Tell your prescriber and pharmacist what you take.

• Liposomal Glutathione

  Antioxidant

  Glutathione is a major intracellular antioxidant, and oxidative stress is one of the things described during infection and during die-off reactions. The liposomal preparation exists because plain oral glutathione is poorly absorbed.

  Evidence grade held for clinician review: The two LymeHQ guides graded this differently, so the grade is removed from both until a clinician reviews it. No trial shows it treats Lyme.

• Vitamin D3 + K2

  Immune Regulation

  Vitamin D receptors are present on most immune cells, and vitamin D is involved in both innate and adaptive responses and in antimicrobial peptide production. Low vitamin D is common in the general population and more so in people who are unwell and spending little time outdoors.

  Clinical (general): Vitamin D's role in immune function is established in general immunology. Whether supplementing changes the course of Lyme has not been shown.

  K2 (MK-7) is combined with D3 on the reasoning that it directs calcium to bone. Vitamin D is measurable in blood, so this is one of the few things here a test can actually answer — worth asking whether yours has been checked.

• Magnesium Glycinate

  Cofactor · Nerve Support

  Magnesium is a cofactor in hundreds of enzymatic reactions including ATP synthesis and nerve signaling, and is commonly depleted in chronic illness. It is used in the community for muscle pain, sleep and anxiety — symptoms often prominent in Lyme.

  Evidence grade held for clinician review: The two LymeHQ guides graded this differently, so the grade is removed from both until a clinician reviews it. No trial shows it treats Lyme.

  The glycinate form is generally described as gentler on digestion than other salts.

  Interaction: Supplements can interact with prescription medicines. Tell your prescriber and pharmacist what you take.

• Omega-3 Fatty Acids

  Anti-Inflammatory

  EPA and DHA shift prostaglandin production toward less inflammatory pathways. That mechanism is described in general immunology; what it amounts to during a Lyme infection specifically has not been measured.

  Clinical (general): Anti-inflammatory effects are studied in other conditions. No trials in Lyme.

  Fish oil and krill oil differ in how the fatty acids are carried, and people report tolerating them differently.

  Interaction: Supplements can interact with prescription medicines. Tell your prescriber and pharmacist what you take.

• Japanese Knotweed

  Herbal · Buhner protocol

  Contains resveratrol and stilbene compounds. Notable for crossing the blood-brain barrier, making it one of the few herbs discussed in the context of neurological Lyme. Also acts as an anti-inflammatory through NF-κB modulation.

  Preclinical: Laboratory studies suggest anti-Borrelia activity and anti-inflammatory effects. No human clinical trials confirm efficacy for Lyme.

  Used as adjunctive support alongside conventional treatment, not as a replacement.

  Interaction: Supplements can interact with prescription medicines. Tell your prescriber and pharmacist what you take.

• N-Acetyl Cysteine (NAC)

  Antioxidant · Glutathione Precursor

  NAC is a precursor the body uses to make glutathione, and a mucolytic in respiratory medicine. It has been studied in the laboratory against bacterial biofilms — but whether biofilm forms occur in people with Lyme at all is one of the unresolved questions this page names above, so that laboratory work is not a reason to expect an effect here.

  Preclinical: Laboratory work only, and against a target whose existence in human infection is itself unsettled. No human trials in Lyme.

• Cat's Claw (Uncaria tomentosa)

  Herbal · Immune Modulation

  Contains pentacyclic oxindole alkaloids that modulate NF-κB signaling — the same inflammatory pathway disrupted during Borrelia infection. Often described as an immune regulator rather than a stimulant, which matters for patients with dysregulated immunity.

  Preclinical: Lab studies suggest immune-modulating and possible anti-Borrelia activity. Not confirmed in human Lyme trials.

  Used as immune support alongside treatment.

• Coenzyme Q10 (CoQ10)

  Mitochondrial Support

  CoQ10 is part of the mitochondrial electron transport chain. Mitochondrial dysfunction has been proposed as one contributor to the fatigue described in chronic illness generally; how much of the fatigue in Lyme it accounts for is not established.

  Evidence grade held for clinician review: The two LymeHQ guides graded this differently, so the grade is removed from both until a clinician reviews it. No trial shows it treats Lyme.

  The ubiquinol form is absorbed more readily than ubiquinone.

Discuss anything here with your provider before starting it. Supplements can interact with prescription medicines; tell your prescriber and pharmacist what you take.

The same pathogen, the same treatment, very different outcomes. Here is what is described about why.

What follows are associations described across groups of patients — not a score, a ranking, or a prediction about you. They also overlap heavily with each other: the person who was treated late is often the person who was never told what to look for, and the person carrying three infections is often the person who was ill for a year before anyone looked. No one has separated these from each other, and the two labels below say how much weight a factor is usually given, not how much it applies to any individual.

• Time to Treatment

  Major influence

  How long the infection went untreated. Treated later, Borrelia has had time to disseminate, establish intracellular refuges, begin antigenic variation, and partially suppress the adaptive immune response. What this comparison cannot separate: people treated early are usually people who saw a rash, and an infection that announced itself may not be the same illness as one that never did.

• Coinfection Burden

  Major influence

  Each additional pathogen adds immune load, adds its own evasion mechanisms, and often needs separate treatment. Doxycycline has no activity against Babesia, which is a parasite rather than a bacterium, so an undiagnosed Babesia infection can survive a Lyme course that worked. What this comparison cannot separate: people who turn out to carry several infections have often been unwell for longer before anyone went looking.

• Genetic Immune Variation

  Contributing

  HLA gene variants affect how efficiently the adaptive immune system recognizes and responds to Borrelia antigens, and certain HLA-DR variants have been associated with more severe Lyme arthritis. This is one of the explanations offered for why the same exposure can produce very different illnesses in two people. It is not something a clinic test currently sorts out for you.

• Sleep, Stress & Immune Function

  Contributing

  In general immunology, sustained sleep loss reduces NK cell activity, T cell function and antibody production, and sustained stress raises cortisol, which damps the immune response. That is a description of a mechanism, not a measurement of anyone in particular — and being too unwell to sleep is a symptom of this illness at least as often as it is a cause of a slow recovery. Nothing here is a verdict on how you have handled being ill.

• Gut Microbiome Health

  Contributing

  A large share of the body's immune tissue sits in gut-associated lymphoid tissue (GALT). A disrupted gut — common after antibiotic treatment — is associated with altered immune regulation, more inflammatory signaling, and less production of the short-chain fatty acids that gut immune cells use. This is why gut effects during Lyme treatment are discussed as an immune question and not only a comfort one.

• Underlying Immune Status

  Contributing

  Pre-existing immune dysfunction, autoimmune conditions, mold or mycotoxin exposure, and nutrient deficiencies all affect baseline immune capacity. Someone who was already depleted starts from a different place than someone who was not. Whether correcting any of that before or during treatment changes the outcome has not been shown, and is a question for the clinician treating you rather than a reason to buy anything.

Why symptoms sometimes persist after antibiotics have cleared the infection — and what it means for recovery.

Post-Treatment Lyme Disease Syndrome (PTLDS) is the label used for symptoms that continue after a completed course of standard treatment. How many people it affects depends heavily on how the syndrome is defined and who is counted, and published estimates differ widely enough that no single figure belongs on a page that cannot show you where it came from. The immune mechanisms behind it are actively researched and none of them is settled. These are the explanations currently under investigation:

• Immune Dysregulation

  Months of immune evasion and disruption by Borrelia leave the immune system in a dysregulated state — inflammatory pathways remain activated even after the pathogen is cleared. The immune system is still firing at a target that's no longer there, producing symptoms through ongoing cytokine activity rather than active infection.

• Neurological Damage & Neuroinflammation

  Borrelia in the CNS triggers microglial activation — the brain's immune cells. Once activated, microglia can maintain a neuroinflammatory state independent of active infection. Brain fog, cognitive symptoms, and mood changes in PTLDS may reflect ongoing neuroinflammation rather than active bacterial presence.

• Possible Persistent Infection

  A more controversial hypothesis: cyst-form or biofilm Borrelia may survive antibiotic courses and reactivate after treatment ends. Animal studies and some clinical observations are cited in support of it; it is not established in people. The debate between "immune dysregulation" and "persistent infection" is not resolved — both may be true in different patients, which is why it has direct consequences for how treatment decisions get made.